{"organizations": [], "uuid": "f9d30fce3d34e52463f7d001c293c8b5bc4662d0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180501.html", "section_title": "Archive News &amp; Video for Tuesday, 01 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-iterum-therapeutics-files-for-ipo/brief-iterum-therapeutics-files-for-ipo-of-up-to-92-mln-idUSFWN1S80LN", "country": "US", "domain_rank": 408, "title": "BRIEF-Iterum Therapeutics Files For IPO Of Up To $92 Mln", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.023, "site_type": "news", "published": "2018-05-02T05:32:00.000+03:00", "replies_count": 0, "uuid": "f9d30fce3d34e52463f7d001c293c8b5bc4662d0"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-iterum-therapeutics-files-for-ipo/brief-iterum-therapeutics-files-for-ipo-of-up-to-92-mln-idUSFWN1S80LN", "ord_in_thread": 0, "title": "BRIEF-Iterum Therapeutics Files For IPO Of Up To $92 Mln", "locations": [], "entities": {"persons": [{"name": "leerink", "sentiment": "none"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 1 (Reuters) -\n* ITERUM THERAPEUTICS LTD FILES FOR INITIAL PUBLIC OFFERING OF UP TO $92 MILLION - SEC FILING\n* ITERUM THERAPEUTICS LTD APPLIED TO LIST ITS ORDINARY SHARES ON NASDAQ GLOBAL SELECT MARKET UNDER THE SYMBOL “ITRM”\n* ITERUM THERAPEUTICS LTD SAYS LEERINK PARTNERS, RBC CAPITAL MARKETS, GUGGENHEIM SECURITIES AND NEEDHAM & COMPANY ARE UNDERWRITERS TO IPO\n* ITERUM THERAPEUTICS LTD - PROPOSED IPO PRICE IS AN ESTIMATE SOLELY FOR PURPOSE OF CALCULATING SEC REGISTRATION FEE\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-02T05:32:00.000+03:00", "crawled": "2018-05-02T16:19:41.000+03:00", "highlightTitle": ""}